India to Chile: Fluticasone Export Trade Route

The India to Chile Fluticasone corridor is one of India's established pharmaceutical export routes, with 231 shipments documented worth a combined $7.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's fluticasone manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $33.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with fluticasone's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 13.7%, placing it at rank #3 among India's top fluticasone export destinations globally.

On the import side, key buyers of Indian fluticasone in Chile include LABORATORIOS RECALCINE SA.., TO THE ORDER OF, LABORATORIOS RECALCINE SA and 16 others. LABORATORIOS RECALCINE SA.. is the single largest importer with 54 shipments valued at $1.6M USD.

India's fluticasone exports to Chile are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 110 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Chile benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, HETERO LABS LIMITED, HETERO LABS LIMITED — together account for 95% of total trade value on this route. The average shipment value of $33.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as aurituss inhaler (25/250) (salmeterol xinafoate 25mcg + fluticasone propionate 250mcg (1x120 md) and flusacort salmeterol +fluticasone propionate inhaler, suggesting that buyers in Chile tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABORATORIOS RECALCINE SA.. is the largest importer with 54 shipments worth $1.6M USD — representing 20% of all fluticasone imports from India on this route. A total of 19 buyers are active on this corridor.